Contact Us
Drug Search Results
More Filters [+]

Carbimazole

Alternative Names: carbimazole
Latest Update: 2024-05-14
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: Iodine Inhibitor

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Algeria | Australia | Austria | Bangladesh | Cyprus | Denmark | Dominican Republic | Egypt | Finland | France | Greece | Hong Kong | Iceland | India | Indonesia | Ireland | Jordan | Korea | Malaysia | Malta | Morocco | Netherlands | New Zealand | Norway | Pakistan | Philippines | Saudi Arabia | Singapore | South Africa | Spain | Sri Lanka | Switzerland | Taiwan | Ukraine | United Arab Emirates | United Kingdom | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Newcastle-upon-Tyne Hospitals NHS Trust
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Carbimazole

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Graves Disease

Phase 3: Thyrotoxicosis|Graves Disease|Hyperthyroidism

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
TRIBUTE

N/A

Completed

Hyperthyroidism

2023-05-19

COVID-19

N/A

Completed

Severe Acute Respiratory Syndrome|COVID-19|Hypothyroidism|Hyperthyroidism

2021-09-30

ChoPS

P3

Unknown status

Hyperthyroidism|Graves Disease

2018-03-01

ACTRN12615000362594

P4

Terminated

Graves Disease

2016-09-06

Recent News Events

Date

Type

Title

05/14/2024

PubMed

 Eltroxin and Hesperidin mitigate testicular and renal damage in hypothyroid rats: amelioration of oxidative stress through PPARγ and Nrf2/HO-1 signaling pathway.

05/02/2024

PubMed

 Cardiac evaluation in amiodarone-induced thyroid dysfunction with suspected cardiac ischemia?: a case report and review of the literature.

03/15/2024

PubMed

 Lemierre's Syndrome Caused by Streptococcus pneumoniae in a Patient with Carbimazole-Induced Severe Neutropenia.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions